RecruitingNot applicableNCT06543537

Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer

Studying Malignant epithelial tumor of ovary

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Dana-Farber Cancer Institute
Principal Investigator
Rachel Pozzar, PhD
Dana-Farber Cancer Institute
Intervention
Collaborative Agenda-Setting Intervention(behavioral)
Enrollment
112 target
Eligibility
18 years · FEMALE
Timeline
2025 – 2026

Study locations (1)

Collaborators

National Institute of Nursing Research (NINR)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06543537 on ClinicalTrials.gov

Other trials for Malignant epithelial tumor of ovary

Additional recruiting or active studies for the same condition.

See all trials for Malignant epithelial tumor of ovary →

← Back to all trials